The global medical device outsourcing market size is calculated at USD 180.76 billion in 2025 and is forecasted to reach around USD 525.53 billion by 2034, accelerating at a CAGR of 12.61% from 2025 to 2034. The Asia Pacific medical device outsourcing market size surpassed USD 75.73 billion in 2025 and is expanding at a CAGR of 12.87% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Medical Device Outsourcing Market, by Service Type, 2025-2034
7.1.1. Product Upgrade Services
7.1.1.1. Market Revenue and Forecast (2022-2034)
7.1.2. Regulatory Affairs Services
7.1.2.1. Market Revenue and Forecast (2022-2034)
7.1.3. Quality Assurance
7.1.3.1. Market Revenue and Forecast (2022-2034)
7.1.4. Product Maintenance Services
7.1.4.1. Market Revenue and Forecast (2022-2034)
7.1.5. Product Testing & Sterilization Services
7.1.5.1. Market Revenue and Forecast (2022-2034)
7.1.6. Product Design and Development Services
7.1.6.1. Market Revenue and Forecast (2022-2034)
7.1.7. Product Implementation Services
7.1.7.1. Market Revenue and Forecast (2022-2034)
7.1.8. Contract Manufacturing
7.1.8.1. Market Revenue and Forecast (2022-2034)
8.1. Medical Device Outsourcing Market, by Application, 2025-2034
8.1.1. Drug Delivery
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Dental
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Diabetes care
8.1.3.1. Market Revenue and Forecast (2022-2034)
8.1.4. Cardiology
8.1.4.1. Market Revenue and Forecast (2022-2034)
8.1.5. Endoscopy
8.1.5.1. Market Revenue and Forecast (2022-2034)
8.1.6. IVD
8.1.6.1. Market Revenue and Forecast (2022-2034)
8.1.7. Ophthalmic
8.1.7.1. Market Revenue and Forecast (2022-2034)
8.1.8. Diagnostic imaging
8.1.8.1. Market Revenue and Forecast (2022-2034)
8.1.9. Orthopedic
8.1.9.1. Market Revenue and Forecast (2022-2034)
8.1.10. General and plastic surgery
8.1.10.1. Market Revenue and Forecast (2022-2034)
8.1.11. Others
8.1.11.1. Market Revenue and Forecast (2022-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Service (2022-2034)
9.1.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Service (2022-2034)
9.1.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Service (2022-2034)
9.1.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Service (2022-2034)
9.2.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Service (2022-2034)
9.2.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Service (2022-2034)
9.2.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Service (2022-2034)
9.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Service (2022-2034)
9.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Service (2022-2034)
9.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Service (2022-2034)
9.3.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Service (2022-2034)
9.3.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Service (2022-2034)
9.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Service (2022-2034)
9.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Service (2022-2034)
9.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Service (2022-2034)
9.4.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Service (2022-2034)
9.4.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Service (2022-2034)
9.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Service (2022-2034)
9.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Service (2022-2034)
9.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Service (2022-2034)
9.5.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Service (2022-2034)
9.5.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.1. Intertek Group PLC
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. TüvSüd AG
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Wuxi Apptec
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. SGS SA
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Toxikon, INC.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Eurofins Scientific
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. American Preclinical Services
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Sterigenics International LLC
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Pace Analytical Services LLC.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. North American Science Associates, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Charles River Laboratories International, Inc.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client